METAGENICS CALCITITE PROTECT

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

calcium hydrogen phosphate dihydrate, Quantity: 474.5 mg (Equivalent: calcium, Qty 111.5 mg); borax, Quantity: 8.85 mg (Equivalent: boron, Qty 1 mg); hydroxyapatite, Quantity: 1 g (Equivalent: phosphorus, Qty 120 mg; Equivalent: calcium, Qty 255 mg); colecalciferol, Quantity: 0.0083 mg; phytomenadione, Quantity: 27 microgram

Verfügbar ab:

Metagenics (Aust) Pty Ltd

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: magnesium stearate; povidone; silicon dioxide; crospovidone; croscarmellose sodium; macrogol 8000; stearic acid; hyprolose; powdered cellulose; microcrystalline cellulose; maize starch; Acacia; dl-alpha-tocopherol; medium chain triglycerides; sucrose

Verabreichungsweg:

Oral

Anwendungsgebiete:

Aids/assists teeth development ; Maintain/support bone health ; Aids/assists healthy bone development/growth/building ; Helps enhance/promote bone mass/density ; Maintain/support bone mass/density/integrity ; Helps enhance/promote bone strength ; Maintain/support bone strength ; Help maintain/support bone mineralisation ; A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate ; Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; Helps enhance/improve/promote/increase muscle strength to improve balance/stability ; Maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; Maintain/support (state vitamin/mineral/nutrient) levels in the body

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Listed

Berechtigungsdatum:

2019-08-26